Shareholders Equity (Quarterly) Chart

Historical Shareholders Equity (Quarterly) Data

View and export this data back to 2009. Upgrade now.
Date Value
December 31, 2023 54.22M
June 30, 2023 34.42M
March 31, 2023 105.80M
December 31, 2022 168.81M
June 30, 2022 -28.68M
March 31, 2022 158.20M
December 31, 2021 277.25M
September 30, 2021 692.75M
March 31, 2021 679.52M
December 31, 2020 764.20M
September 30, 2020 702.13M
June 30, 2020 738.36M
March 31, 2020 737.53M
December 31, 2019 442.13M
September 30, 2019 484.76M
June 30, 2019 526.48M
March 31, 2019 523.74M
December 31, 2018 558.65M
September 30, 2018 617.28M
June 30, 2018 576.84M
March 31, 2018 419.94M
December 31, 2017 430.30M
September 30, 2017 435.77M
June 30, 2017 448.70M
March 31, 2017 429.14M
Date Value
December 31, 2016 439.21M
September 30, 2016 370.21M
June 30, 2016 381.02M
March 31, 2016 400.39M
December 31, 2015 396.58M
September 30, 2015 421.80M
June 30, 2015 428.79M
March 31, 2015 422.72M
December 31, 2014 424.15M
September 30, 2014 441.38M
June 30, 2014 476.91M
March 31, 2014 476.27M
December 31, 2013 486.27M
September 30, 2013 476.69M
June 30, 2013 289.68M
March 31, 2013 271.97M
December 31, 2012 267.16M
September 30, 2012 255.78M
June 30, 2012 245.32M
March 31, 2012 263.10M
December 31, 2011 255.35M
September 30, 2011 271.86M
June 30, 2011 292.24M
March 31, 2011 290.55M
December 31, 2010 247.27M

Shareholders' Equity Definition

Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.

Read full definition.

Shareholders Equity (Quarterly) Range, Past 5 Years

-28.68M
Minimum
Jun 2022
764.20M
Maximum
Dec 2020
408.62M
Average
463.45M
Median

Shareholders Equity (Quarterly) Benchmarks

Incyte Corp 5.394B
Novartis AG 39.68B
Immatics NV 248.81M
Affimed NV 63.90M
InflaRx NV 113.39M

Shareholders Equity (Quarterly) Related Metrics